Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

merckincweb1

NICE approves MSD’s Keytruda for new cancer indication

December 1, 2016 Medical Communications, Sales and Marketing MSD, NICE, keytruda

The National Institute of Health and Care Excellence (NICE) has announced its recommendation of MSD’s immunotherapy drug Keytruda (pembrolizumab) for …
News
kitepharma_fullcolor_rgb

Kite Pharma names new senior VP of Supply Chain

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, kite pharma

Santa-Monica-based clinical-stage biopharmaceutical firm Kite Pharma has appointed Dr Jian Irish as senior vice president of Supply Chain, who will …
Appointment
takeda_tokyo_hq

Takeda to build €100 million dengue vaccine manufacturing plant

December 1, 2016 Manufacturing and Production, Medical Communications Takeda, dengue, phase 3

Takeda have announced plans to spend more than €100 million in the construction of a new manufacturing plant in Singen, …
News
eisai_halaven_eribulin_web

Eisai & Clinigen to bring breast cancer drug to South Africa

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, Eisai, South Africa, breast cancer

Eisai and Clinigen have formed a collaboration to deliver the former’s cancer treatment Halaven (eribulin) to women in South Africa …
News
ncri-harpal-hero

Cancer Research UK announces “largest ever” development investment

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer Research UK

Cancer Research UK (CRUK) is set to inject a total of £226 million into centres across the UK over the …
News
happy_doctor

Illegal psilocybin shows promise in treatment of depression

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johns Hopkins, Magic mushrooms, psilocybin

A double-blind study of psilocybin, the hallucinogenic drug chemical found in ‘magic mushrooms’,  has been found to have substantial mental …
News
actinium_pharma

Actinium snatches up ex-Novartis clinical manager

November 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actinium, Novartis, appointment

Actinium Pharmaceuticals has appointed Gregory Bergonio to the position of director of Clinical Operations, where he will first guide the …
Appointment
ireena_vittal

Ireena Vittal joins Cipla executive board

November 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, appointment

Indian drug maker Cipla has expanded its board with the addition of Ireena Vittal as an independent director, effective 1 …
Appointment

PrimeVigilance and PharmInvent combine to create leading, international full service pharmacovigilance, medical information and regulatory service provider

November 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PrimeVigilance and PharmInvent are pleased to announce that they are now working together as an integrated service provider following the …
News
Press release
cmglee_cambridge_cancer_research_web

UK oral cancer rates soar 68% over two decades

November 29, 2016 Manufacturing and Production, Medical Communications, Research and Development Cancer Research UK, Oral cancer, mouth cancer

As a move to raise awareness during Mouth Cancer Action Month, Cancer Research UK (CRUK) has released figures of an …
News
shutterstock_57369385

Biosimilars and Generics: A no-brainer for treatment?

November 28, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, generics

The industry is poised on the potential widespread adoption of many revolutionary technologies; foremost among them are biosimilars and generics, …
Feature
uday_baldota

Taro announces appointment of new CEO

November 25, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Taro pharmaceutical, sun pharmaceutical

Taro Pharmaceutical announced that Uday Baldota will take up the position of CEO and will begin the role in early …
Appointment
top_ten_1

Top Ten most popular articles on Pharmafile this week

November 25, 2016 Medical Communications November, news, pharmaceutical, top 10, top ten, top ten stories

This week has seen the pharmaceutical industry return to business as usual after the presidential election provided a boost to …
News
deb_lancaster

Insider interview: Roche discusses efficacy of CDF and NICE

November 25, 2016 Medical Communications, Sales and Marketing CDF, NICE, Roche

Deborah Lancaster, Head of Market Access at Roche, discusses, in the latest issue of Pharmafile, the efficacy of the National …
News
nice_aerial

Lowered price wins NICE approval for Janssen leukaemia treatment

November 25, 2016 Medical Communications, Sales and Marketing Janssen, NICE, SMC, chronic lymphocytic leukaemia, ibrutinib, imbruvica

After being knocked back in the beginning of June this year, NICE has announced that Janssen’s Imbruvica (ibrutinib) will now …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026